Nome Químico: (5aR,5bS,5cS,6S,7aS,7bS,10aR,11aS,11bS)-6-Hydroxy-7b-(2-hydroxyacetyl)-5b,7a-dimethyl-9-propyl-1,5a,5b,5c,6,7,7a,7b,10a,11,11a,11b-dodecahydrocyclopenta[2'',3'']cyclopropa[1'',2'':3',4']benzo[1',2':4,5]indeno[1,2-d][1,3]dioxol-5(2H)-one
Sorrisos: O=C1C=CC2(CC[C@]3([H])[C@]4([H])[C@@H](O)C[C@@]5(C)[C@@]3([H])C[C@@H](OC(CCC)O6)[C@]56C(CO)=O)[C@]4(C)[C@@]12[H]
Inchi: InChI=1S/C32H40N2O/c1-32(2,3)27-15-16-28(35-4)26(21-27)22-33-30-25-17-19-34(20-18-25)31(30)29(23-11-7-5-8-12-23)24-13-9-6-10-14-24/h5-16,21,25,29-31,33H,17-20,22H2,1-4H3/t30-,31-/m1/s1
A validated stability indicating UHPLC method for the determination of anti-inflammatory corticosteroid budesonide epimers
By Vaddi, Lakshmi; Purushothaman, Vijayanthimala; Gowda, Nagaraj
From Journal of Pharmaceutical Sciences and Research (2020), 12(6), 848-852
Analytical method development and validation of formoterol fumarate and budesonide in pressurized meter dose inhaler form by using RP-HPLC
By Raghu, P. S.
From European Journal of Biomedical and Pharmaceutical Sciences (2018), 5(6), 1-6
Isolation and characterization of photodegradation impurity in budesonide drug product using LC-MS and NMR spectroscopy
By Bhutnar, Arun; Khapare, Sachin; Desai, Anita; Dsouza, Smitha
From American Journal of Analytical Chemistry (2017), 8(7), 449-461